Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1344-1356
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1344
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1344
Figure 3 Example of an alfapump complication.
An alfapump® was implanted in July 2018, followed by omphalectomy in September 2018. A: October 2018: Increase in ascites after omphalectomy, leading to modification of the alfapump® settings and enabling subsequent deferral of paracentesis; B: February 2020: The patient was hospitalized for sepsis related to infection of the pump pocket, complicated with peritonitis and requiring pump explantation (Personal communication, Dr D. Weil-Verhoeven, CHU Besançon).
- Citation: Weil-Verhoeven D, Di Martino V, Stirnimann G, Cervoni JP, Nguyen-Khac E, Thévenot T. Alfapump® implantable device in management of refractory ascites: An update. World J Hepatol 2022; 14(7): 1344-1356
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1344.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1344